{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:13:32Z","timestamp":1740107612715,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:00:00Z","timestamp":1560297600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T00:00:00Z","timestamp":1560297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K10089"],"award-info":[{"award-number":["16K10089"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00595-019-01832-7","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T16:02:41Z","timestamp":1560355361000},"page":"971-976","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Recombinant human soluble thrombomodulin reduces the severity and incidence of necrotizing enterocolitis in a newborn rat model"],"prefix":"10.1007","volume":"49","author":[{"given":"Bo","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuta","family":"Saka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Takama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehisa","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Tazuke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroomi","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,12]]},"reference":[{"key":"1832_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1056\/NEJMra1005408","volume":"364","author":"J Neu","year":"2011","unstructured":"Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med. 2011;364:255\u201364.","journal-title":"N Engl J Med."},{"key":"1832_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/1471-2431-13-127","volume":"13","author":"V Ganapathy","year":"2013","unstructured":"Ganapathy V, Hay JW, Kim JH, Lee ML, Rechtman DJ. Long term healthcare costs of infants who survived neonatal necrotizing enterocolitis: a retrospective longitudinal study among infants enrolled in Texas Medicaid. BMC Pediatr. 2013;13:127.","journal-title":"BMC Pediatr."},{"key":"1832_CR3","doi-asserted-by":"publisher","first-page":"G917","DOI":"10.1152\/ajpgi.00422.2013","volume":"306","author":"P Lu","year":"2014","unstructured":"Lu P, Sodhi CP, Jia H, Shaffiey S, Good M, Branca MF, et al. Animal models of gastrointestinal and liver diseases. Animal models of necrotizing enterocolitis: pathophysiology, translational relevance, and challenges. Am J Physiol Gastrointest Liver Physiol. 2014;306:G917\u2013928.","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"1832_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ajpath.2014.08.028","volume":"185","author":"SM Tanner","year":"2015","unstructured":"Tanner SM, Berryhill TF, Ellenburg JL, Jilling T, Cleveland DS, Lorenz RG, et al. Pathogenesis of necrotizing enterocolitis: modeling the innate immune response. Am J Pathol. 2015;185:4\u201316.","journal-title":"Am J Pathol."},{"key":"1832_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2174\/138945012799424606","volume":"13","author":"J Morser","year":"2012","unstructured":"Morser J. Thrombomodulin links coagulation to inflammation and immunity. Curr Drug Targets. 2012;13:421\u201331.","journal-title":"Curr Drug Targets."},{"key":"1832_CR6","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1055\/s-0037-1615902","volume":"82","author":"I Maruyama","year":"1999","unstructured":"Maruyama I. Recombinant thrombomodulin and activated protein C in the treatment of disseminated intravascular coagulation. Thromb Haemost. 1999;82:718\u201321.","journal-title":"Thromb Haemost."},{"key":"1832_CR7","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1097\/CCM.0b013e3181a55184","volume":"37","author":"M Nagato","year":"2009","unstructured":"Nagato M, Okamoto K, Abe Y, Higure A, Yamaguchi K. Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia. Crit Care Med. 2009;37:2181\u20136.","journal-title":"Crit Care Med."},{"key":"1832_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/ajt.13991","volume":"17","author":"K Kadono","year":"2017","unstructured":"Kadono K, Uchida Y, Hirao H, Miyauchi T, Watanabe T, Iida T, et al. Thrombomodulin attenuates inflammatory damage due to liver ischemia and reperfusion injury in mice in toll-like receptor 4-dependent manner. Am J Transplant. 2017;17:69\u201380.","journal-title":"Am J Transplant."},{"key":"1832_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pathophys.2013.11.010","volume":"21","author":"CJ Hunter","year":"2014","unstructured":"Hunter CJ, De Plaen IG. Inflammatory signaling in NEC: role of NF-\u03baB, cytokines and other inflammatory mediators. Pathophysiology. 2014;21:55\u201365.","journal-title":"Pathophysiology."},{"key":"1832_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jphs.2015.11.007","volume":"129","author":"W Osumi","year":"2015","unstructured":"Osumi W, Jin D, Imai Y, Tashiro K, Li ZL, Otsuki Y, et al. Recombinant human soluble thrombomodulin improved lipopolysaccharide\/d-galactosamine-induced acute liver failure in mice. J Pharmacol Sci. 2015;129:233\u20139.","journal-title":"J Pharmacol Sci."},{"key":"1832_CR11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1152\/ajprenal.00558.2011","volume":"302","author":"G Rajashekhar","year":"2012","unstructured":"Rajashekhar G, Gupta A, Marin A, Friedrich J, Willuweit A, Berg DT, et al. Soluble thrombomodulin reduces inflammation and prevents microalbuminuria induced by chronic endothelial activation in transgenic mice. Am J Physiol Renal Physiol. 2012;302:703\u201312.","journal-title":"Am J Physiol Renal Physiol."},{"key":"1832_CR12","first-page":"687","volume":"77","author":"B Barlow","year":"1975","unstructured":"Barlow B, Santulli TV. Importance of multiple episodes of hypoxia or cold stress on the development of enterocolitis in an animal model. Surgery. 1975;77:687\u201390.","journal-title":"Surgery."},{"key":"1832_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.peptides.2015.07.025","volume":"75","author":"K Nakame","year":"2016","unstructured":"Nakame K, Kaji T, Mukai M, Shinyama S, Matsufuji H. The protective and anti-inflammatory effects of glucagon-like peptide-2 in an experimental rat model of necrotizing enterocolitis. Peptides. 2016;75:1\u20137.","journal-title":"Peptides"},{"key":"1832_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1053\/j.sempedsurg.2005.05.005","volume":"14","author":"J Feng","year":"2005","unstructured":"Feng J, El-Assal ON, Besner GE. Heparin-binding EGF-like growth factor (HB-EGF) and necrotizing enterocolitis. Semin Pediatr Surg. 2005;14:167\u201374.","journal-title":"Semin Pediatr Surg."},{"key":"1832_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1152\/ajpgi.00196.2001","volume":"282","author":"B Dvorak","year":"2002","unstructured":"Dvorak B, Halpern MD, Holubec H, Williams CS, McWilliam DL, Dominguez JA, et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal ratmodel. Am J Physiol Gastrointest Liver Physiol. 2002;282:156\u201364.","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"1832_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1053\/j.sempedsurg.2017.11.006","volume":"27","author":"GJ Ares","year":"2018","unstructured":"Ares GJ, McElroy SJ, Hunter CJ. The science and necessity of using animal models in the study of necrotizing enterocolitis. Semin Pediatr Surg. 2018;27:29\u201333.","journal-title":"Semin Pediatr Surg."},{"key":"1832_CR17","first-page":"39","volume":"23","author":"RM Rentea","year":"2013","unstructured":"Rentea RM, Welak SR, Fredrich K, Donohoe D, Pritchard KA, Oldham KT, et al. Early enteral stressors in newborns increase inflammatory cytokine expression in a neonatal necrotizing enterocolitis rat model. Eur J Pediatr Surg. 2013;23:39\u201347.","journal-title":"Eur J Pediatr Surg."},{"key":"1832_CR18","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1046\/j.1523-1755.2002.00160.x","volume":"61","author":"H Ikeguchi","year":"2002","unstructured":"Ikeguchi H, Maruyama S, Morita Y, Fujita Y, Kato T, Natori Y, et al. Effects of human soluble thrombomodulin on experimental glomerulonephritis. Kidney Int. 2002;61:490\u2013501.","journal-title":"Kidney Int."},{"key":"1832_CR19","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1161\/ATVBAHA.107.150631","volume":"28","author":"T Ito","year":"2008","unstructured":"Ito T, Kawahara K, Okamoto K, Yamada S, Yasuda M, Imaizumi H, et al. Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulincomplexes. Arterioscler Thromb Vasc Biol. 2008;28:1825\u201330.","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"1832_CR20","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1164\/ajrccm.164.10.2106117","volume":"164","author":"H Wang","year":"2001","unstructured":"Wang H, Yang H, Czura CJ, Sama AE, Tracey KJ. HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med. 2001;164:1768\u201373.","journal-title":"Am J Respir Crit Care Med."},{"key":"1832_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature00858","volume":"418","author":"P Scaffidi","year":"2002","unstructured":"Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418:191\u20135.","journal-title":"Nature"},{"key":"1832_CR22","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1172\/JCI200114002","volume":"108","author":"AM Schmidt","year":"2001","unstructured":"Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest. 2001;108:949\u201355.","journal-title":"J Clin Invest."},{"key":"1832_CR23","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1172\/JCI22782","volume":"115","author":"K Abeyama","year":"2005","unstructured":"Abeyama K, Stern DM, Ito Y, Kawahara K, Yoshimoto Y, Tanaka M, et al. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J Clin Invest. 2005;115:1267\u201374.","journal-title":"J Clin Invest."},{"key":"1832_CR24","doi-asserted-by":"publisher","first-page":"G643","DOI":"10.1152\/ajpgi.00067.2005","volume":"289","author":"R Zamora","year":"2005","unstructured":"Zamora R, Grishin A, Wong C, Boyle P, Wang J, Hackam D, et al. High-mobility group box 1 protein is an inflammatory mediator in necrotizing enterocolitis: protective effect of the macrophage deactivator semapimod. Am J Physiol Gastrointest Liver Physiol. 2005;289:G643\u2013652.","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"1832_CR25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jpedsurg.2005.10.018","volume":"41","author":"J Feng","year":"2006","unstructured":"Feng J, El-Assal ON, Besner GE. Heparin-binding epidermal growth factor-like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats. J Pediatr Surg. 2006;41:144\u20139.","journal-title":"J Pediatr Surg."},{"key":"1832_CR26","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.jpedsurg.2011.03.023","volume":"46","author":"CD Downard","year":"2011","unstructured":"Downard CD, Grant SN, Matheson PJ, Guillaume AW, Debski R, Fallat ME, et al. Altered intestinal microcirculation is the critical event in the development of necrotizing enterocolitis. J Pediatr Surg. 2011;46:1023\u20138.","journal-title":"J Pediatr Surg."},{"key":"1832_CR27","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.3760\/cma.j.issn.0366-6999.20121741","volume":"126","author":"HY Zhang","year":"2013","unstructured":"Zhang HY, Wang F, Feng JX. Intestinal microcirculatory dysfunction and neonatal necrotizing enterocolitis. Chin Med J (Engl). 2013;126:1771\u20138.","journal-title":"Chin Med J (Engl)."},{"key":"1832_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1053\/j.sempedsurg.2013.01.004","volume":"22","author":"DJ Watkins","year":"2013","unstructured":"Watkins DJ, Besner GE. The role of the intestinal microcirculation in necrotizing enterocolitis. Semin Pediatr Surg. 2013;22:83\u20137.","journal-title":"Semin Pediatr Surg."}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-019-01832-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00595-019-01832-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-019-01832-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T16:43:35Z","timestamp":1721407415000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00595-019-01832-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,12]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1832"],"URL":"https:\/\/doi.org\/10.1007\/s00595-019-01832-7","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"type":"print","value":"0941-1291"},{"type":"electronic","value":"1436-2813"}],"subject":[],"published":{"date-parts":[[2019,6,12]]},"assertion":[{"value":"12 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest in association with this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}